Mixed COVID-19 run of Roche’s Actemra drug continues after failed trial with Gilead’s remdesivir
ZURICH (SWITZERLAND) - Swiss drugmaker Roche said on Thursday that mixing its drug Actemra to Gilead ...
Read moreZURICH (SWITZERLAND) - Swiss drugmaker Roche said on Thursday that mixing its drug Actemra to Gilead ...
Read moreZURICH (SWITZERLAND) - Swiss drugmaker Roche's chairman, Christoph Franz, favours requiring people to get a vaccination ...
Read moreLONDON (UK) - The National Health Service said on Tuesday that Roche has alerted hospitals about ...
Read moreZURICH (SWITZERLAND) - Swiss drugmaker Roche said on Thursday that its sales and profit in the ...
Read moreZURICH (Business) - Swiss contract drug manufacturer Lonza Group on Friday named Roche manager Pierre-Alain Ruffieux ...
Read more(Business) - Roche Holding AG received emergency use approval from the U.S. Food and Drug Administration ...
Read moreZURICH (Business) - Roche's diagnostic business has moved out of the shadows of its main medicines ...
Read moreZURICH- Roche has won fast-track review status in the United States for a new diagnostic approach ...
Read moreZURICH - Swiss drugmaker Roche is coughing up to $1.4 billion (£1 billion) towards buying U.S. ...
Read more